We are Donaldson.

MINNEAPOLIS (June 14, 2022)—A new chapter has begun for Purilogics, with more resources and dedication to biologics production. Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced the acquisition of Purilogics, LLC. “We are excited about the value Purilogics brings to the Donaldson life sciences portfolio through its novel and differentiated products,” said Tod Carpenter, chairman, president, and chief executive officer of Donaldson. “Our membrane technology expertise, and global sales and manufacturing footprint, will enable faster development and commercialization of these powerful tools for biologics purification.”

Jinxiang Zhou, Ph.D., Co-Founder and Vice President of Purilogics believes, ‘Being a part of Donaldson will provide Purilogics with the global scale and financial flexibility needed to achieve our founding vision – to accelerate the speed of early-stage biologics drug development and improve production efficiency.”

-